
Merck & Co Inc (Derivatives) (MRK) price today
Not listedMarket sentiment
Live MRK chart
Merck & Co Inc (Derivatives) (MRK) price details

Merck & Co Inc (Derivatives) price history
Merck & Co Inc (Derivatives) technical analysis
Merck & Co Inc (Derivatives) (MRK) sentiment
About Merck & Co Inc (Derivatives)
Merck is a global health care company. It offers human health pharmaceutical products across a range of therapeutic areas under brands including Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, VaxNeuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Belsomra, Januvia and Janumet. The company also provides animal health products, vaccines, and health management solutions and services for livestock and companion animals, under brands such as Bravecto, Nobivac, Banamine, Safe-Guard, Zuprevo, Posatex and Sentinel.
Official links
Social media and community
FAQ
What is the current price of Merck & Co Inc (Derivatives) (MRK) in USD?
What is the market capitalization of Merck & Co Inc (Derivatives) (MRK)?
What is the circulating supply of Merck & Co Inc (Derivatives) (MRK)?
What factors influence the price of Merck & Co Inc (Derivatives) (MRK)?
Is Merck & Co Inc (Derivatives) (MRK) a good investment?
Where can I buy Merck & Co Inc (Derivatives) (MRK)?
What are the typical fees when buying Merck & Co Inc (Derivatives) (MRK)?
What are some technical indicators used for analyzing Merck & Co Inc (Derivatives) (MRK)?
Global prices
¥
₽
€
$
¥
NT$
₫
aed
₴
zł
R$
Rp
$
₼
฿
RsHow to buy
Price predictions
Merck & Co Inc (Derivatives) news
Crypto: Netflix Series on FTX Sparks Reactions from CZ and Vitalik Buterin
Solana upgrades to mainnet 1.0 as Foundation takes majority CoinGecko stake
IOSCO Warns of 'Quantum Delay' and Assesses Readiness for Quantum Threat
Deribit outage hit Bitcoin hedgers on Coinbase
Deribit’s Nov. 20 outage disrupted Bitcoin and Ether perpetuals across Coinbase and Deribit. Coinbase said its separate US derivatives were unaffected.
Johnson & Johnson Is on Track for $101 Billion in 2026 Sales. Is This Dividend King Still a Buy?
J&J is a healthcare giant performing very well right now, but it won't be a great fit for every investor.
J.P. Morgan Says Tesla's Robotaxi Fleet Could Match Waymo's Miles by Late 2027 With 18,000 Cars. The Number That Matters Is How Much Each Car Earns.
The robotaxi battle will be won and lost over the total cost of ownership per mile.
What's Going on with The Trade Desk Stock? 3 Reasons Investors Are Losing Confidence.
Is The Trade Desk a turnaround story or a value trap?
Bitcoin’s next big threat could come from two oil tankers in the Middle East
Two reported Hormuz tanker strikes put falling Brent prices to the test. Cargo flows and US rate expectations will shape the implications for Bitcoin.
More to explore



















